Impact of type 2 diabetes mellitus on in-hospital outcomes in patients with ST-elevation myocardial infarction: A nationwide study in Germany

Read full text Summarise with VIRAT
Authors: Volker H. Schmitt, Omar Hahad, Visvakanth Sivanathan, Christoph Brochhausen, Christine Espinola–Klein, Thomas F. Münzel, Philipp C. Lurz, Tommaso Gori, Lukas Hobohm, K K Keller
Cited by: 0
References: 74

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Type 2 diabetes mellitus (T2DM) represents a substantial health burden especially regarding cardiovascular diseases. In this context, the presence of T2DM adversely affects both disease emergence and progression. Therefore, this study investigated the impact of T2DM on outcomes in patients hospitalized for ST-elevation myocardial infarction (STEMI). Methods: We used the nationwide German inpatient statistics of the years 2005-2022 for statistical analysis. Hospitalizations of patients who were admitted due to STEMI in German hospitals were included in this study. The impact of T2DM on in-hospital adverse events was evaluated, whereas patients with type 1 diabetes mellitus (T1DM) were excluded. Results: Overall, data on 1,590,775 hospitalizations of patients admitted due to STEMI were included; among these 379,346 (23.8%) patient-cases had T2DM. STEMI patients with T2DM were older (71.0 [62.0-79.0] vs. 66.0 [55.0-77.0] years, P < 0.001) and had an aggravated comorbidity burden. STEMI patients with T2DM were less often treated with percutaneous coronary intervention (61.2% vs. 66.7%, P < 0.001), whereas coronary-artery bypass graft was more often performed (5.0% vs. 3.9%, P < 0.001). The in-hospital case-fatality was significantly higher in T2DM patients (16.0% vs. 13.3%, P < 0.001).In multivariable analysis, T2DM was independently associated with lower usage of percutaneous intervention (OR 0.89 [95%CI 0.89-0.90], P < 0.001) and increased case-fatality (OR 1.03 [95%CI 1.01-1.04], P < 0.001). Conclusion: In STEMI patients, T2DM was associated with an increased case-fatality and higher complication rate in the light of an underuse of interventional revascularization.

Fields of Study & Subjects

Acute Myocardial Infarction Research Coronary Interventions and Diagnostics Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Metabolism Open
Volume
30
Pages
100462–100462
Publication date
25 March 2026
Language
EN